‘I’ve got two months to find a donor’
Last Christmas, mum-of-twins Meena looked the picture of health. Now she urgently needs to find a stem cell match. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 9, 2018 Category: Consumer Health News Source Type: news

Potential seen for tailoring treatment for acute myeloid leukemia
(University of Washington Health Sciences/UW Medicine) Rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia. Research on the differing drug response patterns of leukemia stem cells and blasts may show why some attempts to treat are not successful and why some patients relapse. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 7, 2018 Category: Cancer & Oncology Source Type: news

Researchers evaluate   pMSCs   sheets for engineered repair and regeneration of heart tissue
(Mary Ann Liebert, Inc./Genetic Engineering News) The placenta offers an abundant source of placenta-derived mesenchymal stem cells (pMSCs), which a new study has shown can readily form cell sheets that could be implanted in children with congenital heart defects and offer benefits for heart repair and regeneration compared to commonly used synthetic material-based scaffolds. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 7, 2018 Category: International Medicine & Public Health Source Type: news

Survival With Second Cancer After Stem Cell Transplant Tied to Cancer Type Survival With Second Cancer After Stem Cell Transplant Tied to Cancer Type
The outcome of second solid cancers following hematopoietic stem cell transplantation (HSCT) is strongly related to cancer type, with pancreatic and lung cancer being among those with the poorest outcome, according to European researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 6, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Medical News Today: Honeybees may hold the secret to stem cell youth
The royal jelly that honeybees make to produce new queen bees seems to contain a secret ingredient that can keep stem cells 'young' and powerful. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 6, 2018 Category: Consumer Health News Tags: Stem Cell Research Source Type: news

Virus- and oncogene-free reprogramming method for the production of iPSCs published in the journal Regenerative Medicine
(Future Science Group) Regenerative Medicine is delighted to publish open access original research demonstrating the first virus- and oncogene-free induced pluripotent stem cell (iPSC) technology to produce safer pluripotent stem cells from cord blood and peripheral blood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2018 Category: International Medicine & Public Health Source Type: news

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday. The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Grou p plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 5, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

This Peninsula biotech foresaw deals worth $3 billion. Now it's lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday. The reverse merger between Redwood City-based OncoMed and Mereo BioPharma Grou p plc will give the London company a U.S. stock listing and seven experimental drugs. If the deal closes as expected in first-half 2019, it would close the books on OncoMed… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 5, 2018 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

New stem cell treatment uses umbilical cord blood for bone marrow patients
A treatment that uses stem cells from umbilical cord blood could be safe for bone marrow transplant patients, a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 5, 2018 Category: Consumer Health News Source Type: news

Asymmetrex Starts New Campaign for Greater Awareness of the Importance of Counting Tissue Stem Cells
Now that Massachusetts stem cell biotechnology company Asymmetrex has developed the first and only technology for specific and accurate counting of therapeutic tissue stem cells, today the company... (Source: The Scientist)
Source: The Scientist - December 5, 2018 Category: Science Tags: The Marketplace The Scientist Source Type: news

UCLA scientist looks to space for possible treatment of some neurological diseases
Do astronauts ’ brains get bigger in space?The answer may be found in 10 small containers of human brain cells on board a SpaceX spacecraft  that is scheduled for blast off Dec. 5 for a 16-month voyage to the International Space Station as part of joint project between UCLA and the NASA Ames Research Center.Astronauts on long-duration space missions frequently develop “intracranial hypertension,” or high pressure within the skull, said Araceli Espinosa-Jeffrey, a neurochemist at UCLA’s Intellectual and Developmental Disabilities Research Center in the Jane and Terry Sem...
Source: UCLA Newsroom: Health Sciences - December 5, 2018 Category: Universities & Medical Training Source Type: news

Pushing 3D Printing Forward
Researchers and students have demonstrated that inks can be used instead of thermoplastic filaments to 3D print functional biomedical devices. Michael McAlpine, Benjamin Mayhugh Associate Professor of Mechanical Engineering at the University of Minnesota, described such advances in the ESC Minneapolis keynote, “3D Printing Functional Materials & Devices.” A lot of the inks McAlpine’s group uses are nanometer-scale particle inks printed at a line-width scale of 10 microns and above for printing devices at the macro level. They have developed software as well as a hig...
Source: MDDI - December 4, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M Minneapolis 3-D Printing Source Type: news

Image of the Day: Scarred Hearts
Maps of diving cells before and after heart attacks in mice offer additional evidence against the existence of cardiac stem cells. (Source: The Scientist)
Source: The Scientist - December 4, 2018 Category: Science Tags: Image of the Day Source Type: news

Expanded cord blood shows potential for use in adult bone marrow transplants
(Duke University Medical Center) Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

FZD5 is a G{alpha}q-coupled receptor that exhibits the functional hallmarks of prototypical GPCRs
Frizzleds (FZDs) are a group of seven transmembrane–spanning (7TM) receptors that belong to class F of the G protein–coupled receptor (GPCR) superfamily. FZDs bind WNT proteins to stimulate diverse signaling cascades involved in embryonic development, stem cell regulation, and adult tissue homeostasis. Frizzled 5 (FZD5) is one of the most studied class F GPCRs that promote the functional inactivation of the β-catenin destruction complex in response to WNTs. However, whether FZDs function as prototypical GPCRs has been heavily debated and, in particular, FZD5 has not been shown to activate heterotrimeric G ...
Source: Signal Transduction Knowledge Environment - December 4, 2018 Category: Science Authors: Wright, S. C., Canizal, M. C. A., Benkel, T., Simon, K., Le Gouill, C., Matricon, P., Namkung, Y., Lukasheva, V., König, G. M., Laporte, S. A., Carlsson, J., Kostenis, E., Bouvier, M., Schulte, G., Hoffmann, C. Tags: STKE Research Articles Source Type: news

Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in relapsed or refractory diffuse large B-cell lymphoma
Roche today announced longer-term data from the phase Ib/II GO29365 study showing that polatuzumab vedotin, an investigational anti-CD79b antibody drug conjugate (ADC), in combination with MabThera ®/Rituxan® (rituximab) plus bendamustine (BR), demonstrated a median overall survival (OS) of over one year compared to the BR arm (12.4 vs. 4.7 months, HR 0.42; 95% CI 0.24, 0.75), in people with R/R DLBCL not eligible for a haematopoietic stem cell transplant. OS was an exploratory endpoint. (Source: Roche Investor Update)
Source: Roche Investor Update - December 3, 2018 Category: Pharmaceuticals Source Type: news

Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in relapsed or refractory diffuse large B-cell lymphoma
Roche today announced longer-term data from the phase Ib/II GO29365 study showing that polatuzumab vedotin, an investigational anti-CD79b antibody drug conjugate (ADC), in combination with MabThera ®/Rituxan® (rituximab) plus bendamustine (BR), demonstrated a median overall survival (OS) of over one year compared to the BR arm (12.4 vs. 4.7 months, HR 0.42; 95% CI 0.24, 0.75), in people with R/R DLBCL not eligible for a haematopoietic stem cell transplant. OS was an exploratory endpoint. (Source: Roche Media News)
Source: Roche Media News - December 3, 2018 Category: Pharmaceuticals Source Type: news

Dana-Farber to present new research on stem cell transplantation for myeloid cancers
(Dana-Farber Cancer Institute) Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation is a focus of several studies to be presented by Dana-Farber Cancer Institute scientists at the ASH Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 3, 2018 Category: Cancer & Oncology Source Type: news

A study connects the genetic background of autistic spectrum disorders with stem cell dysfunction
(University of Helsinki) A recently completed study provides new information on functional changes in the brain connected with autistic spectrum disorders. The findings help identify factors related to the individual manifestation of autistic spectrum disorders and associated diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 3, 2018 Category: International Medicine & Public Health Source Type: news

Does She Have SCID?
Discussion Severe-combined immunodefiency (SCID) is actually a group of inherited disorders with an absence or dysfunction of T, B and NK cells that results in severe dysfunction of the immune system. SCID is a primary immunodeficiency. SCID was thought to be a rare disorder but with the advent of neonatal screening the incidence in the US general population is estimated at ~1 in 58,000 live births, but with numbers higher or lower depending on the specific population. Patients often have failure to thrive, oral candidiasis, and diarrhea as infants as well as a variety of infectious diseases. They can also have interstit...
Source: PediatricEducation.org - December 3, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Single or Double Autologous Transplantation in New Myeloma Cases?
Researchers analyzed double vs single autologous stem cell transplantation in patients with newly diagnosed multiple myeloma, after previous conflicting results. (Source: CancerNetwork)
Source: CancerNetwork - December 2, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Fat Cells Shrink to Make Room for Milk in Breastfeeding Mouse Moms
Adipocytes lose their lipids and reprogram themselves into stem cells during lactation, then turn back into fat cells after pups wean. (Source: The Scientist)
Source: The Scientist - December 1, 2018 Category: Science Tags: The Literature Magazine Issue Source Type: news

Screening LSCs For AML Drug Resistance, Sensitivity
Researchers used high throughput drug screening on leukemic stem cells to determine drug resistance and sensitivity in acute myeloid leukemia patients. (Source: CancerNetwork)
Source: CancerNetwork - November 30, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Allogeneic Transplantation in Elderly AML Patients
Allogeneic hematopoietic stem cell transplantation could improve outcomes of elderly patients with acute myeloid leukemia. (Source: CancerNetwork)
Source: CancerNetwork - November 30, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

RenovaCare chairman ponies up nearly $16m for wound-healing stem cell SkinGun
RenovaCare (Scottsdale, Ariz.) has announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Harmel Rayat, who is the majority shareholder and chairman of RenovaCare. The equity financing increases his family office’s total equity investment in RenovaCare to over $20 million. “Our long-term investment in RenovaCare speaks to our conviction that patients worldwide urgently need and deserve our regenerative SkinGun therapy, which sprays a patient’s own stem cells for rapid self-healing,” Rayat said in a press release. “I’m more confident...
Source: Mass Device - November 30, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Regenerative Medicine Stem Cells RenovaCare Source Type: news

Some blood cells have a surprising source: Your gut
(Columbia University Irving Medical Center) The human intestine may provide up to 10 percent of blood cells in circulation from its own reservoir of blood-forming stem cells, a surprising new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 29, 2018 Category: International Medicine & Public Health Source Type: news

A stem cell-integrated microneedle patch
(Source: ScienceNOW)
Source: ScienceNOW - November 29, 2018 Category: Science Authors: Benson, P. J. Tags: twis Source Type: news

Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight Only Three Days Left to Apply! Call for Applications to the MLA Research Training Institute (RTI) – Apply by December 1 for this week-long residential workshop that provides librarians and library information professionals with the opportunity to work intensively on research design and planning to conduct research that improves practice and adds to the professional knowledgebase. The workshop will be held in Chicago from July 15–19, 2019. National Network of Libraries of Medicine News The MAR offices will be clo...
Source: NN/LM Middle Atlantic Region Blog - November 28, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Since their discovery in 2006, induced pluripotent stem cells have been poised to reprogram regenerative medicine. Twelve years on, here's how far they've come. (Source: The Scientist)
Source: The Scientist - November 28, 2018 Category: Science Tags: News & Opinion Source Type: news

New stem-cell therapy to improve fight against leukemia
(University of Zurich) Stem-cell transplantation is an effective form of therapy to fight leukemia. In many cases, however, the transferred immune cells of the donor also attack the recipients' healthy tissue - often with fatal consequences. Researchers at the University of Zurich have now identified a molecule that plays a key role in this process. Blocking this molecule could significantly improve the outcome of patients receiving stem-cell transplants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 28, 2018 Category: Cancer & Oncology Source Type: news

Healthy blood stem cells have as many DNA mutations as leukemic cells
(Princess Máxima Center for Pediatric Oncology) Researchers from the Princess M á xima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ. Rather the location of the mutations in the DNA is relevant. Using the mutation patterns in the hematopoietic stem and progenitor cells (HSPCs) the team was able to trace the developmental lineage tree of the cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

Upcoming Training Opportunities: December 2018
Looking for professional development opportunities? The National Network of Libraries of Medicine offers a variety of online classes to learn about new resources and programs, and develop your professional skills. All of our classes are free, and many are eligible for continuing education credit from the Medical Library Association. Even if you will not be able to attend a live webinar, you can still register to receive a notification when the recording is available on the NNLM YouTube Channel. Check out some of our December 2018 offerings and register today! Don’t do it alone! Starting, sustaining, and assessing par...
Source: NN/LM Middle Atlantic Region Blog - November 27, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Education Source Type: news

Next for Disabling Back Pain? New Discs From Patients' Own Cells
TUESDAY, Nov. 27, 2018 -- People with disabling back pain may one day receive replacement spinal discs grown from their own stem cells, researchers say. Preliminary results in goats are encouraging, according to the University of Pennsylvania... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 27, 2018 Category: General Medicine Source Type: news

BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
CAMBRIDGE, Mass., Nov. 26, 2018 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced ... Regenerative Medicine, Personnel BlueRock Therapeutics, stem cell, Cell+Gene (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 26, 2018 Category: Pharmaceuticals Source Type: news

Citrate-based biomaterial fuels bone healing with less rejection
(Penn State) A material based on a natural product of bones and citrus fruit, called citrate, provides the extra energy that stem cells need to form new bone tissue, according to a team of Penn State bioengineers. Their new understanding of the mechanism that allows citrate to aid in bone regeneration will help the researchers develop slow-release, biodegradable, citrate-releasing scaffolds to act as bone-growth templates to speed up healing in the body. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 26, 2018 Category: International Medicine & Public Health Source Type: news

Fred Hutch at ASH: Press briefing on CAR T-cell therapy, CRISPR for blood disorders, more
(Fred Hutchinson Cancer Research Center) Fred Hutchinson Cancer Research Center's latest findings on cancer immunotherapies, CRISPR for blood disorders, stem cell transplantation and insights on the immune system and cancer will be featured at the 60th annual meeting of the American Society of Hematology, which will be held Dec. 1-4 in San Diego. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 26, 2018 Category: Cancer & Oncology Source Type: news

Changing concepts in hematopoietic stem cells
(Source: ScienceNOW)
Source: ScienceNOW - November 22, 2018 Category: Science Authors: Yamamoto, R., Wilkinson, A. C., Nakauchi, H. Tags: perspective Source Type: news

Medical manufacturer makes acquisition in California
Direct Biologics LLC, a science-based manufacturer of regenerative medical products, has acquired California-based Paisley Laboratories. Terms of the deal were not disclosed. The acquisition will help the St. Louis-based company expand its ability to develop innovative and revolutionary products based on utilizing human mesenchymal stem cells, officials said in a statement. More than 60 million people in the U.S. currently have some type of joint or spine pain, and 1 2 million interventional procedures… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 19, 2018 Category: Biotechnology Authors: Veneta Rizvic Source Type: news

Medical manufacturer makes acquisition in California
Direct Biologics LLC, a science-based manufacturer of regenerative medical products, has acquired California-based Paisley Laboratories. Terms of the deal were not disclosed. The acquisition will help the St. Louis-based company expand its ability to develop innovative and revolutionary products based on utilizing human mesenchymal stem cells, officials said in a statement. More than 60 million people in the U.S. currently have some type of joint or spine pain, and 1 2 million interventional procedures… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 19, 2018 Category: Health Management Authors: Veneta Rizvic Source Type: news

Proposed cancer treatment may boost lung cancer stem cells, study warns
(Boston Children's Hospital) Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston Children's Hospital now report that at least one epigenetic therapy that initially looked promising for lung cancer actually has the opposite effect, boosting cancer stem cells that are believed to drive tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2018 Category: International Medicine & Public Health Source Type: news

Stem Cell Adjunct to LVAD Trial Negative, But'Intriguing'Stem Cell Adjunct to LVAD Trial Negative, But'Intriguing '
A new study did not show overall benefit on cardiac function, but there did appear to be an improvement in patients with ischemic heart failure and a large reduction in GI bleeding.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Treating the 'bubble babies'
(University of Montreal) A new study shows that the genotype of a child with severe combined immune deficiency (SCID) affects his survival rate after stem cell transplantation from an unrelated donor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2018 Category: International Medicine & Public Health Source Type: news

In vivo modeling of human neuron dynamics and Down syndrome
Harnessing the potential of human stem cells for modeling the physiology and diseases of cortical circuitry requires monitoring cellular dynamics in vivo. We show that human induced pluripotent stem cell (iPSC)–derived cortical neurons transplanted into the adult mouse cortex consistently organized into large (up to ~100 mm3) vascularized neuron-glia territories with complex cytoarchitecture. Longitudinal imaging of>4000 grafted developing human neurons revealed that neuronal arbors refined via branch-specific retraction; human synaptic networks substantially restructured over 4 months, with balanced rates of syna...
Source: ScienceNOW - November 15, 2018 Category: Science Authors: Real, R., Peter, M., Trabalza, A., Khan, S., Smith, M. A., Dopp, J., Barnes, S. J., Momoh, A., Strano, A., Volpi, E., Knott, G., Livesey, F. J., De Paola, V. Tags: Neuroscience, Online Only r-articles Source Type: news

Parkinson's Patient Transplanted with Neurons Derived from iPSCs
This is the first time researchers have tested the use of the reprogrammed stem cells in the human brain. (Source: The Scientist)
Source: The Scientist - November 14, 2018 Category: Science Tags: News & Opinion Source Type: news

AHA: Stem Cells No Help in LVAD Patients
(MedPage Today) -- Mesenchymal precursor cells didn't boost wean rates from heart assist devices (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - November 13, 2018 Category: Surgery Source Type: news

Osteopontin: A new emerging role in HCV-related hepatocellular carcinoma
(Kanazawa University) A research team based in Japan led by Kanazawa University has demonstrated the effect of osteopontin on hepatitis C virus replication and interferon signaling in cancer stem cells. Their research sheds light on a novel therapeutic target for treating hepatocellular carcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2018 Category: Cancer & Oncology Source Type: news

Cancer stem cells get energy from protein, and it's proving to be their Achilles' heel
(University of Colorado Anschutz Medical Campus) CU Cancer Center study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Clinical trial based on this observation may revolutionize care for older adults with acute myeloid leukemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 12, 2018 Category: International Medicine & Public Health Source Type: news

20-year-old woman dies from a stem-cell transplant
Keziah Shorten was in intensive care for six months after having the operation in Italy and died of pneumonia after a second transplant carried out by University College London in 2011 also failed. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2018 Category: Consumer Health News Source Type: news

Japan team transplants stem cells into brain of Parkinson's patient
Scientists from Kyoto University injected induced pluripotent stem (iPS) cells into the man. Worldwide, about 10million people have the illness, according to the Parkinson's Disease Foundation. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2018 Category: Consumer Health News Source Type: news

Asymmetrex Intensifies Campaign to Increase Awareness of the Adult...
Since September of this year, stem cell biotechnology company Asymmetrex has been leading a campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine and the...(PRWeb November 07, 2018)Read the full story at https://www.prweb.com/releases/asymmetrex_intensifies_campaign_to_increase_awareness_of_the_adult_tissue_stem_cell_counting_problem/prweb15899192.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 7, 2018 Category: Pharmaceuticals Source Type: news